Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma

Microbes and Infection

Volumn 2, Issue 6, 2000, Pages 671-680

  Gruffat, Henri ^a   Sergeant, Alain ^a   Manet, Evelyne ^a  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

Cell transformation; Human herpesvirus 8; Kaposi's sarcoma; KSHV; Rhadinovirus

Indexed keywords

GENE STRUCTURE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; RHADINOVIRUS;

EID: 0034094143     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00358-0     Document Type: Review

References (61)

1. Ensoli B., Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 266:1998;63-83.
2. Chang Y., Cesarman E., Pessin M.S., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science. 93:1994;1865-1869.
3. Boshoff C. Kaposi's sarcoma associated herpesvirus, in Infections and human cancer. 1999;157-190 Imperial Cancer Research Fund. Editor.
4. Russo J.J., Bohenzky R.A., Chien M.C., et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 71:1996;14862-14867.
5. Neipel F., Albrecht J.C., Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 236:1997;4187-4192.
6. Lagunoff M., Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 1997;147-154.
7. Nicholas J., Zong J.C., Alcendor D.J., et al. Novel organizational features, captured cellular genes, strain variability within the genome of KSHV/HHV8. J. Natl. Cancer Inst. Monogr. 73:1998;79-88.
8. Zong J.C., Ciufo D.M., Alcendor D.J., et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 284:1999;4156-4170.
9. Ballestas M.E., Chatis P.A., Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 71:1999;641-644.
10. Rainbow L., Platt G.M., Simpson G.R., et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 72:1997;5915-5921.
11. Muralidhar S., Pumfery A.M., Hassani M., et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene [published erratum appears in J. Virol. (1999) Mar;73 (3):2568]. J. Virol. 73:1998;4980-4988.
12. Sadler R., Wu L., Forghani B., et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:1999;5722-5730.
13. Glenn M., Rainbow L., Aurad F., et al. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J. Virol. 73:1999;6953-6963.
14. Poole L.J., Zong J.C., Ciufo D.M., et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J. Virol. 18:1999;6646-6660.
15. Lee H., Guo J., Li M., et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell Biol. 4:1998;5219-5228.
16. Lee H., Veazey R., Williams K., et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat. M. 96:1998;435-440.
17. Lagunoff M., Majeti R., Weiss A., et al. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 15:1999;5704-5709.
18. Gao S.J., Boshoff C., Jayachandra S., et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene. 72:1997;1979-1985.
19. Zimring J.C., Goodbourn S., Offermann M.K. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 73:1998;701-707.
20. Burysek L., Yeow W.S., Lubyova B., et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 96:1999;7334-7342.
21. Jayachandra S., Low K.G., Thlick A.E., et al. Three unrelated viral transforming proteins (vIRF, EBNA2, E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl. Acad. Sci. USA. 2:1999;11566-11571.
22. Burysek L., Yeow W.S., Pitha P.M. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 71:1999;19-32.
23. Li M., Lee H., Yoon D.W., et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71:1997;1984-1991.
24. Godden-Kent D., Talbot S.J., Boshoff C., et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 390:1997;4193-4198.
25. Swanton C., Mann D.J., Fleckenstein B., et al. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature. 18:1997;184-187.
26. Ellis M., Chew Y.P., Fallis L., et al. Degradation of p27 (Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 89:1999;644-653.
27. Davis M.A., Sturzl M.A., Blasig C., et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells [see comments]. J. Natl. Cancer Inst. 71:1997;1868-1874.
28. Neipel F., Albrecht J.C., Ensser A., et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 91:1997;839-842.
29. Burger R., Neipel F., Fleckenstein B., et al. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells [see comments]. Blood. 3:1998;1858-1863.
30. Nicholas J., Ruvolo V.R., Burns W.H., et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. M. 272:1997;287-292.
31. Molden J., Chang Y., You Y., et al. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL- 6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 73:1997;19625-19631.
32. Wan X., Wang H., Nicholas J. Human Herpesvirus 8 Interleukin-6 (vIL-6) Signals through gp130 but has Structural and Receptor-Binding Properties Distinct from Those of Human IL-6. J. Virol. 93:1999;8268-8278.
33. Aoki Y., Jaffe E.S., Chang Y., et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 [see comments]. Blood. 73:1999;4034-4043.
34. Staskus K.A., Sun R., Miller G., et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, multicentric Castleman's disease. J. Virol. 278:1999;4181-4187.
35. Boshoff C., Endo Y., Collins P.D., et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [see comments]. Science. 277:1997;290-294.
36. Kledal T.N., Rosenkilde M.M., Coulin F., et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science. 92:1997;1656-1659.
37. Sozzani S., Luini W., Bianchi G., et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood. 189:1998;4036-4039.
38. Endres M.J., Garlisi C.G., Xiao H., et al. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR) 8. J. Exp. M. 274:1999;1993-1998.
39. Dairaghi D.J., Fan R.A., Mc Master B.E., et al. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J. Biol. Chem. 92:1999;21569-21574.
40. Sozzani S., Luini W., Bianchi G., Allavena P., Wells T.N., C, Napolitano M., Bernardini G., Vecchi A., D'Ambrosio D., Mazzeo D., Sinigaglia F., Santoni A., Maggi E., Romagnani S., Mantovani A. The Viral Chemokine Macrophage Inflammatory Protein-II Is a Selective Th2 Chemoattractant. Blood. 385:1998;4036-4039.
41. Arvanitakis L., Geras-Raaka E., Varma A., et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [see comments]. Nature. 391:1997;347-350.
42. Bais C., Santomasso B., Coso O., et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [see comments] [published erratum appears in Nature (1998) Mar 12;392 (6672):210]. Nature. 274:1998;86-89.
43. Munshi N., Ganju R.K., Avraham S., et al. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-Jun amino-terminal Kinase/Stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine Kinase/Proline-rich tyrosine kinase 2 [In Process Citation]. J. Biol. Chem. 187:1999;31863-31867.
44. Geras-Raaka E., Arvanitakis L., Bais C., et al. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. J. Exp. M. 102:1998;801-806.
45. Gershengorn M.C., Geras-Raaka E., Varma A., et al. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture [see comments]. J. Clin. Invest. 188:1998;1469-1472.
46. Geras-Raaka E., Varma A., Ho H., et al. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. M. 253:1998;405-408.
47. Geras-Raaka E., Varma A., Clark-Lewis I., et al. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem. Biophys. Res. Commun. 274:1998;725-727.
48. Ho H.H., Du D., Gershengorn M.C. The N terminus of Kaposi's sarcoma-associated herpesvirus G protein- coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity [In Process Citation]. J. Biol. Chem. 73:1999;31327-31332.
49. Kirshner J.R., Staskus K., Haase A., et al. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J. Virol. 388:1999;6006-6014.
50. Irmler M., Thome M., Hahne M., et al. Inhibition of death receptor signals by cellular FLIP. Nature. 91:1997;190-195.
51. Sturzl M., Hohenadl C., Zietz C., et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 3:1999;1725-1733.
52. Sarid R., Sato T., Bohenzky R.A., et al. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat. M. 94:1997;293-298.
53. Cheng E.H., Nicholas J., Bellows D.S., et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA. 72:1997;690-694.
54. Friborg J. Jr, Kong W.P., Flowers C.C., et al. Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas. J. Virol. 95:1998;10073-10082.
55. Sun R., Lin S.F., Gradoville L., et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 19:1998;10866-10871.
56. Manet E., Rigolet A., Gruffat H., et al. Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA-binding and activation. Nucleic Acids Res. 5:1991;2661-2667.
57. Chevallier-Greco A., Manet E., Chavrier P., et al. Both Epstein-Barr virus (EBV) encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 80:1986;3243-3249.
58. Gruffat H., Portes-Sentis S., Sergeant A., et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. J. Gen. Virol. 394:1999;557-561.
59. Flore O., Rafii S., Ely S., et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 73:1998;588-592.
60. Moses A.V., Fish K.N., Ruhl R., et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 282:1999;6892-6902.
61. Gallo R.C. The enigmas of Kaposi's sarcoma. Science. 1998;1837-1839.